Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'.
Affiliation
Center of Health Informatics, Farr Institute@HeRC, Institute of Population Health, University of Manchester, ManchesterIssue Date
2016-05-24
Metadata
Show full item recordCitation
Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'. 2016, 114 (11):e11 Br J CancerJournal
British Journal of CancerDOI
10.1038/bjc.2016.99PubMed ID
27219288Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2016.99
Scopus Count
Collections
Related articles
- Reply to 'Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''.
- Authors: Lu Y, Rodríguez LA, Malgerud L, González-Pérez A, Martín-Pérez M, Lagergren J, Bexelius TS
- Issue date: 2016 May 24
- New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.
- Authors: Lu Y, García Rodríguez LA, Malgerud L, González-Pérez A, Martín-Pérez M, Lagergren J, Bexelius TS
- Issue date: 2015 Dec 1
- The use of glycated haemoglobin (HbA1(C)) in determining glycemic control (and relevance of BMI) in diabetic patients in Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
- Authors: Mustafa IO, Tanko Y, Yusuf R, Musa SA
- Issue date: 2019 Sep-Oct
- Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer - a population-based nationwide case-control study.
- Authors: Sadr-Azodi O, Gudbjörnsdottir S, Ljung R
- Issue date: 2015 Jul
- Characterization of the deterioration of diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive study.
- Authors: Mueller AM, Meier CR, Jick SS, Schneider C
- Issue date: 2022 Apr